Novartis is developing a new platform for the clinical trial of a new drug.
Public source
Company
Novartis
- Industry
- Pharmaceutical Manufacturing
- Location
- Basel, CH
- Company size
- 10,001+ employees
About Novartis
Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki
See moreLatest activity
Latest activity from Novartis
44 signals
Partnerships
Novartis and The Max Foundation have partnered for 25 years to help ensure cancer care breakthroughs reach more patients around the world.
Research & Knowledge
Novartis published in the journal NEJM the clinical trial JY231 for lentiviral in vivo CD19 CAR T-cell therapy in neurologic autoimmune disorders.
People
Novartis appointed Gloria F. as Director Strategy International, leading strategic initiatives across International markets.
Discover more
Similar signals
Similar public activity from other companies.
Strategy & Corporate Development
Sandoz
Sandoz announced the Bio100 goal, aiming to build a portfolio of more than 100 biosimilars by 2040 and expand biosimilar loss-of-exclusivity coverage to 80% from 2035.
Strategy & Corporate Development
Sanofi
Sanofi announced that it will be the first company in the world to launch a new product line for the treatment of Alzheimer's disease.
Strategy & Corporate Development
Crescent Pharma Ltd
Crescent Pharma Ltd is developing a new product line for the treatment of chronic pain.
Strategy & Corporate Development
Lōkahi Therapeutics
Lōkahi Therapeutics expanded its AI² platform into three business divisions spanning 13 universities, more than 45 therapeutic asset evaluations, and three dedicated business divisions.
Strategy & Corporate Development
Milla Pharmaceuticals, an A.forall company